Potassium-Enriched Salt Substitutes Could Prevent Millions of Global Cardiovascular Deaths
Replacing conventional salt with potassium-enriched alternatives offers a low-cost strategy to reduce global mortality.
1Global Health Impact Assessment
A comprehensive study across 193 countries suggests that replacing regular table salt with a potassium-enriched substitute could prevent 2.96 million deaths annually. This transition aims to address 10.17 million new cases of cardiovascular and chronic kidney disease each year, while also saving 69.43 million disability-adjusted life years globally.
2Mechanism of Dietary Intervention
The substitute functions by replacing a portion of sodium chloride with potassium chloride. This dual-action approach simultaneously lowers excessive sodium intake and boosts insufficient potassium levels, both of which are primary drivers of hypertension. The product maintains the taste, appearance, and cooking properties of standard salt, facilitating easier consumer adoption.
3Hypertension and Cardiovascular Risks
High blood pressure remains a critical risk factor for strokes, heart attacks, and kidney failure. Approximately 1.4 billion adults aged 30 to 79 currently suffer from hypertension. With cardiovascular disease causing 19.2 million deaths in 2023, researchers view this dietary shift as a scalable, low-cost alternative to traditional drug-based medical treatments.
4Targeting Household and Industrial Sources
Researchers analyzed various implementation scenarios, including household cooking and processed food sectors. Replacing salt in home kitchens alone could prevent 1.85 million deaths annually. Meanwhile, targeting processed foods and restaurant meals could prevent an additional 1.56 million deaths, particularly in Europe and North America where industry-sourced salt dominates dietary intake.
5Regional Benefits and Population Scale
The potential health gains are most pronounced in nations with large populations and high cardiovascular disease burdens. A complete transition could prevent 1.08 million deaths annually in China and nearly 400,000 in India. In the United Kingdom, full adoption is estimated to prevent 13,000 deaths and 60,000 disease cases every year.
6Managing Hyperkalaemia Clinical Risks
Wider adoption presents risks for individuals with advanced kidney disease or those taking specific medications that elevate potassium levels. These groups face potential hyperkalaemia, an excessive blood potassium concentration. Experts suggest that these risks are manageable through rigorous patient education, clear product labelling, and consistent clinical oversight by medical professionals.
7Institutional Support and Implementation
The World Health Organization endorsed potassium-enriched salt in 2025 as a viable method for reducing blood pressure and cardiovascular risk. Despite this backing, experts acknowledge that a global shift requires significant expansion of potassium chloride production to meet demand, representing an ambitious but necessary step for international public health policy.
8Future Outlook for Salt Policy
While global implementation remains aspirational, researchers emphasize that this strategy offers greater potential than many existing pharmaceutical interventions at a fraction of the cost. The focus now shifts toward engaging the food industry in North America and Europe to integrate these substitutes into processed goods, potentially transforming global cardiovascular health outcomes.